Chia CW, Odetunde JO, Kim W, Carlson OD, Ferrucci L, Egan JM (2014) GIP contributes to islet trihormonal abnormalities in type 2 diabetes
This matters if you are managing side effects
In order to validate our results that the pharmaceutical properties of peptide 1 can be improved by substituting amino acids with oligourea triads, we conducted a series of IPGTT studies on the three best hybrids 14 , 22 and 23 with peptide 1 as control (Fig
Participants taking 12mg lost an average of 28.7% body weight, approximately 71 pounds
Edvardsson CE, Adermark L, Gottlieb S, Alfreji S, Emous TA, Gouda Y, Thorsell A, Vujii M, Arans C, Benrick A, Wernstedt Asterholm I, Lopez MF, Becker HC, Jerlhag E
What I found in reviewing the data is that most gastrointestinal side effects peaked during dose escalation and reduced once participants reached their maintenance dose